TeleZen MD review

What it is

TeleZen MD is a founder-led, Florida-based cash-pay telehealth platform run by Lina and Eric Viner, selling compounded medication across ten categories: GLP-1 weight loss and GLP-1 microdosing, a Strength line built on sermorelin, an Energy line built on NAD⁺, metabolic support injections (MIC and MIC+B12), women's hormone therapy (estradiol, estriol, progesterone), glutathione, PT-141, methylene blue, women's hair growth and prescription skincare (tretinoin, hydroquinone). It names four physicians on its team, states US 503A compounding pharmacies without naming them, and claims all 50 states subject to eligibility and state regulation — a claim it makes on its own authority.

How it works

Asynchronous. You complete a short online intake, connect with a licensed medical provider, and if a prescription is appropriate medication ships with free expedited delivery stated as included. Two things sit on the credit side and are unusual for a platform this size. It names individual physicians rather than describing an anonymous network, and it states the concentration on its injectables — NAD⁺ at 1,000 mg/mL, glutathione at 200 mg/mL — which is the specification that actually lets you compare products rather than compare monthly fees. Against that, the site is difficult to verify from outside: the legal entity name and state of incorporation are not disclosed, no LegitScript certification is confirmed, the compounding pharmacies are described only as "U.S.-based FDA-registered" without names, and the all-50-states claim is unverified. It is also worth noting for anyone testing the site themselves that its origin refuses connections from some IP ranges, which is a bot-protection posture rather than an outage. Payments run through Klarna, Affirm and Afterpay, and it states FSA and HSA eligibility.

Pricing transparency

This is where TeleZen MD loses the benefit of the doubt. Its compounded sermorelin injection publishes $148 for the first month, $198 a month after, a $498 quarterly plan and — on the NAD⁺ equivalent — $898 semi-annual and $1,598 annual. Its compounded NAD⁺ injection at 1,000 mg/mL publishes exactly those five figures. Its compounded GLP-1 plan publishes exactly those five figures. Three molecules with different raw material costs, different vial economics and different dosing cadences do not converge on one ladder by chance, and the strongest evidence that this is a template is the exception: its glutathione injection runs $108 first month then $158, with $398 quarterly, $548 semi-annual and $998 annual — different numbers on the same page structure. Its NAD⁺ nasal spray also differs, at $98 first month then $148 for 300 mg in 15 mL, or $148 then $198 for 300 mg in 30 mL. Because we cannot tell which of the shared figures is a real per-molecule price and which is inherited furniture, we publish no floor on either board. There is a separate issue for budgeting even if the numbers are real: the headline on every product is the discounted first month, and the ongoing rate is $50 higher. Ask what your second charge will be, in writing.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The platform states its medication comes from US 503A compounding pharmacies described as FDA-registered — a phrase worth reading carefully, because registration of a facility and FDA approval of a drug are different things, and neither makes a compounded preparation an approved product. No pharmacy is named. On evidence, the catalog spans several tiers at once. Sermorelin is a GHRH analogue acting on a real, well-described growth-hormone axis with thin long-term human outcome data. Injected and intranasal NAD⁺ have no controlled human outcome trials; the oral precursors NR and NMN are the studied forms and raise a blood level rather than an outcome. Injectable glutathione and GHK-Cu have essentially no controlled human outcome data behind the skin, detoxification and repair claims made for them. Methylene blue is an approved drug for methaemoglobinaemia being sold for cognitive and mitochondrial claims with no controlled human outcome trials behind them, and it interacts seriously with serotonergic medications including SSRIs — disclose every medication you take at intake. PT-141 is approved for one narrow indication in premenopausal women, so other prescribing is off-label use. Individual results vary.

Pros and watch-outs

The evidence behind what TeleZen MD prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• NAD injections: how to get them near you or online, and what the evidence really says

  Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

• NAD⁺ nasal spray: the delivery format with the least direct evidence

  Intranasal NAD⁺ is convenient and heavily marketed — but no controlled human trial shows the spray raises systemic or brain NAD⁺. A straight comparison with the better-studied routes.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

• PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approved

  Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

• Methylene blue: the longevity 'biohack' that's actually a drug

  Low-dose methylene blue has a plausible mitochondrial mechanism and a real single-dose memory signal — but it's an FDA-approved drug, not a supplement, its anti-aging claims are preclinical, and it can cause fatal serotonin syndrome with antidepressants.

How TeleZen MD compares

A few alternatives worth a look, depending on what you’re optimizing for.

• TETelePeptide

  NAD⁺ buyers who want the month-to-month rate published beside the prepay rates

  See TelePeptide →
• THTrava Health

  Buyers who want six named pharmacies and will confirm the NAD⁺ figure against the product page, not the tile

  See Trava Health →
• TWTyde Wellness

  NAD⁺ buyers who want five named pharmacies, a published state list and the route stated with the price

  See Tyde Wellness →